669 related articles for article (PubMed ID: 7889211)
1. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
2. Role of nitric oxide in impaired coronary circulation and improvement by angiotensin II receptor antagonist in spontaneously hypertensive rats.
Fujita H; Takeda K; Nakamura K; Uchida A; Takenaka K; Itoh H; Nakata T; Sasaki S; Nakagawa M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S148-50. PubMed ID: 9072332
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
Friberg P
Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
[TBL] [Abstract][Full Text] [Related]
7. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism.
Kett MM; Alcorn D; Bertram JF; Anderson WP
J Hypertens; 1996 Jan; 14(1):107-13. PubMed ID: 12013482
[TBL] [Abstract][Full Text] [Related]
8. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
Kanagawa R; Wada T; Sanada T; Ojima M; Inada Y
Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
[TBL] [Abstract][Full Text] [Related]
9. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
Mizuno K; Niimura S; Katoh K; Fukuchi S
Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
13. Chronic angiotensin blockade with candesartan cilexetil in DOCA/salt hypertensive rats reduces cardiac hypertrophy and coronary resistance without affecting blood pressure.
Fujita H; Takeda K; Miki S; Morimoto S; Kawa T; Uchida A; Itoh H; Nakata T; Sasaki S; Nakagawa M
Hypertens Res; 1997 Dec; 20(4):263-7. PubMed ID: 9453261
[TBL] [Abstract][Full Text] [Related]
14. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
15. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
[TBL] [Abstract][Full Text] [Related]
16. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
Nunez E; Hosoya K; Susic D; Frohlich ED
Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
[TBL] [Abstract][Full Text] [Related]
18. Age-related increase in sensitivity for ischemic ATP breakdown in hypertrophic hearts of SHR normalized by enalapril.
Schoemaker RG; Leenen FH; Harmsen E
J Mol Cell Cardiol; 1994 May; 26(5):649-60. PubMed ID: 8072019
[TBL] [Abstract][Full Text] [Related]
19. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.
Nishikimi T; Yamagishi H; Takeuchi K; Takeda T
Cardiovasc Res; 1995 Jun; 29(6):856-61. PubMed ID: 7656290
[TBL] [Abstract][Full Text] [Related]
20. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]